Novo Nordisk A/S
NONOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $20,006 | $26,503 | $29,034 | $28,230 |
| Dep. & Amort. | $3,237 | $4,833 | $3,830 | $5,198 |
| Deferred Tax | $0 | $7,302 | $7,999 | $7,327 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$4,960 | $4,755 | -$16,428 | -$981 |
| Other Non-Cash | $27,824 | -$2,608 | $156 | -$27,473 |
| Operating Cash Flow | $46,107 | $40,785 | $24,591 | $12,301 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13,628 | -$14,661 | -$13,422 | -$16,101 |
| Net Acquisitions | $0 | $0 | $0 | -$81,495 |
| Inv. Purchases | $0 | -$582 | -$115 | -$353 |
| Inv. Sales/Matur. | $0 | $2,609 | $8,028 | $7,191 |
| Other Inv. Act. | -$1,797 | -$1,614 | -$1,164 | -$458 |
| Investing Cash Flow | -$15,425 | -$14,248 | -$6,673 | -$91,216 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$433 | -$19,622 | $15,331 | $44,326 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$1,388 | -$7,491 |
| Dividends Paid | -$16,663 | $174 | -$35,274 | $0 |
| Other Fin. Act. | $0 | -$26,782 | $26,782 | $0 |
| Financing Cash Flow | -$17,096 | -$46,230 | $5,451 | $36,835 |
| Forex Effect | $63 | -$810 | -$86 | $717 |
| Net Chg. in Cash | $13,649 | -$20,503 | $23,283 | -$41,363 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,435 | $38,938 | $15,655 | $57,018 |
| End Cash | $32,084 | $18,435 | $38,938 | $15,655 |
| Free Cash Flow | $32,479 | $24,510 | $10,005 | -$4,257 |